When Pap Is Not Enough — Use ThinPrep for Higher CIN Detection
Why Conventional Pap Tests May Miss Early CIN For more than half a century, the Papanicolaou test—or Pap smear—has been the backbone of cervical cancer prevention programs worldwide. It has saved countless lives by enabling the early detection of pre-cancerous lesions. Yet, despite its population-level success, clinicians and cytotechnologists have long recognized its intrinsic limitations. […]
Why HPV Genotyping Matters — Especially for OB-GYNs
While HPV testing has long been a cornerstone of women’s health screening, traditional “positive or negative” results offer limited guidance for clinicians. For OB-GYNs, this lack of detail can mean uncertainty in triage, follow-up, and patient counseling. HPV genotyping changes that. By identifying the exact viral strain, it transforms screening from a simple detection test […]
Why Pap + HPV DNA Is Not Overkill—It’s Best Practice
For decades, the Pap smear has been the frontline defense against cervical cancer. It’s a test that’s saved countless lives, but in today’s era of precision medicine, relying on the Pap alone is no longer considered best practice. The combination of Pap cytology and HPV DNA testing—known as co-testing—offers a far more powerful and reliable […]